age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
33.67798
|
female
| 1
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 14
| null | 0
| 758,539
| 233,276
| 234,875
| 49.5
|
black
| 35.796875
| 58
| 0.658936
| 0.560913
| 14
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 26
| 118
| 13.298828
| 105
| 36
| 37.79688
| 255
| null | 16.796875
| 3.899902
| 147
| 7.469727
| 350
| 66
| 3,025
| null | 0
|
<2 mo. follow-up
| 0
| 26
| 1
|
71.29095
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 117,388
| 42,800.4062
| 44,380.125
| 60
|
black
| 32.695313
| 59
| 0.588989
| 0.47998
| 2
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 5
| 55
| 11.898438
| 100
| 32
| 38.39844
| 131.65625
| null | null | 7.5
| 146
| 7.449219
| 199
| 65
| 753
| null | null |
<2 mo. follow-up
| 2.475098
| 5
| 1
|
59.452
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 12
| null | 0
| 27,070
| null | null | 10.5
|
white
| 13.798828
| 5
| 0.863892
| 0.695923
| 1
| 0
| 0
|
metastatic
| 1
| 0.5
|
no dnr
| 7
| 97
| 9.599609
| 74
| 20
| 38.89844
| null | null | null | 1
| 135
| null | null | 13
| 2,025
| 0
| 2
|
no(M2 and SIP pres)
| 2
| 756
| 1
|
74.97894
|
female
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 18
|
$25-$50k
| 37
| 60,987
| 21,162.5156
| 28,040.5469
| 52
|
white
| 54.59375
| 86
| 0
| 0
| 5
| 0
| 0
|
metastatic
| 0.2
| 0.05
|
dnr after sadm
| 4
| 42
| 13.099609
| 105
| 25
| 35.5
| 121.65625
| 3.299805
| 20
| 2.299805
| 135
| 7.489258
| 178
| 21
| 18
| null | 2
|
<2 mo. follow-up
| 2
| 4
| 1
|
75.67999
|
male
| 1
| 20
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
$25-$50k
| 26
| 122,270
| 41,109.0312
| 64,786.375
| 30.666656
|
white
| 29.898438
| 47
| 0.299988
| 0.188995
| 11
| 0
| 0
|
yes
| 0.65
| 0.25
|
dnr after sadm
| 6
| 115
| 0.299988
| 120
| 6
| 37.79688
| 205
| null | null | 1.599854
| 140
| 7.5
| 183
| 29
| 3,102
| null | 0
|
<2 mo. follow-up
| 0
| 20
| 1
|
65.26196
|
female
| 0
| 14
|
Lung Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 35,260
| 17,061.2188
| 17,638.6094
| 11.666664
|
white
| 7.699219
| 10
| 0.849976
| 0.667969
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 14
| 115
| 10.5
| 100
| 20
| 39
| null | 4.199219
| 0.299988
| 1
| 139
| null | 91
| 13
| 2,050
| 1
| 1
|
no(M2 and SIP pres)
| 1
| 929
| 0
|
65.74896
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 34,253
| 17,195.6094
| 23,903.0781
| 25.5
|
white
| 20.296875
| 17
| 0.856934
| 0.762939
| 1
| 0
| 0
|
no
| 0.65
| 0.5
|
no dnr
| 10
| 62
| 10.298828
| 70
| 22
| 36.19531
| null | 3.299805
| 1.899902
| 1.299805
| 132
| null | 119
| 17
| 5,395
| 5
| null | null | 3.854981
| 689
| 1
|
75.97296
|
male
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$25-$50k
| 0
| 51,180
| 24,631.8281
| 22,223.6875
| 17
|
white
| 21.796875
| 41
| 0.803955
| 0.682983
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 13
| 68
| 13.398438
| 70
| 22
| 39
| null | null | null | 4
| 142
| null | 150
| 34
| 50
| 3
| 3
| null | 3
| 591
| 1
|
72.33899
|
female
| 0
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 37
| 146,792
| 47,670.3125
| 73,489.0625
| 24.333328
|
white
| 17.398438
| 19
| 0.740967
| 0.659912
| 5
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 23
| 132
| 19.296875
| 75
| 16
| 37.69531
| 293.875
| null | null | 0.599976
| 135
| 7.389648
| 149
| 18
| 1,615
| null | 1
| null | 1
| 923
| 0
|
70.62299
|
male
| 0
| 15
|
Lung Cancer
|
Cancer
| 1
| 12
|
$25-$50k
| 0
| 48,292
| 20,661.4688
| 23,549.2656
| 15.333328
|
white
| 25
| 15
| 0.496948
| 0.176971
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.2
|
no dnr
| 15
| 93
| 25.097656
| 104
| 20
| 36.59375
| null | 3.299805
| 0.299988
| 1.299805
| 129
| null | 148
| 19
| 3,250
| 0
| 0
|
<2 mo. follow-up
| 0
| 44
| 1
|
61.80698
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 20
|
>$50k
| 0
| 17,086
| 10,877.5703
| 10,449.0938
| 16
|
white
| 22.796875
| 25
| 0.81189
| 0.695923
| 1
| 0
| 0
|
yes
| 0.8
| 0.6
|
no dnr
| 9
| 73
| 10.099609
| 102
| 32
| 35.79688
| 266.625
| null | null | 1
| 131
| 7.389648
| null | 17
| 2,400
| 1
| 0
| null | 0
| 566
| 1
|
68.758
|
female
| 0
| 9
|
Colon Cancer
|
Cancer
| 1
| 16
| null | 0
| 24,338
| 13,225.6875
| 13,138.7891
| 19
|
white
| 18.296875
| 25
| 0.790894
| 0.55896
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.4
|
no dnr
| 9
| 79
| 8.5
| 76
| 36
| 40.5
| null | null | 0.599976
| 0.699951
| 136
| null | 122
| 4
| 4,450
| null | 0
| null | 0
| 371
| 1
|
32.616
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 8,228
| 4,918.0547
| 4,392.89844
| 6
|
white
| 19.699219
| 25
| 0.930908
| 0.882935
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 4
| 67
| 7.899414
| 120
| 26
| 37.5
| null | null | null | 1.299805
| 139
| null | 113
| 14
| 2,150
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 119
| 1
|
78.48596
|
male
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 26
| 168,174
| 67,323
| 71,125.875
| 30.5
|
white
| 27.296875
| 27
| 0.524902
| 0.408997
| 5
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 33
| 115
| 14
| 65
| 36
| 36.79688
| 320
| null | null | 0.5
| 125
| 7.55957
| 101
| 17
| 1,660
| null | null |
<2 mo. follow-up
| 3.276856
| 37
| 1
|
41.64798
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 14
|
>$50k
| 0
| 16,011
| 7,885.75
| 8,819.71875
| 6
|
white
| 12.398438
| 13
| 0.897949
| 0.765991
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.3
|
no dnr
| 6
| 77
| null | 76
| 22
| 37.69531
| null | null | null | null | 140
| null | null | null | 1,350
| 0
| 0
| null | 0
| 568
| 1
|
55.58398
|
female
| 0
| 110
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 11
|
$11-$25k
| 0
| null | null | null | 50.5
|
white
| 41.5
| 62
| 0.075989
| 0.028
| 24
| 0
| 0
|
metastatic
| 0.5
| 0.5
| null | null | 130
| 19.5
| 125
| 24
| 37.59375
| 81.10938
| 1.699951
| 7.799805
| 0.699951
| 126
| 7.349609
| 188
| 22
| 6,865
| null | null |
SIP>=30
| 2.901856
| 208
| 1
|
64.32898
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 7,735
| 4,253.4219
| 5,050.82812
| 7
|
white
| 16.296875
| 19
| 0.723999
| 0.449951
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.8
|
no dnr
| 4
| 69
| 14.298828
| 66
| 18
| 36.59375
| null | null | null | 1.199951
| 141
| null | 85
| 28
| null | null | null | null | 2.3125
| 71
| 1
|
77.77698
|
female
| 1
| 8
|
Coma
|
Coma
| 1
| 16
|
under $11k
| 89
| 63,572
| 26,724.9844
| 31,751.0781
| 41
|
white
| 34.5
| 69
| 0.011
| 0.004
| 1
| 1
| 0
|
no
| 0.2
| 0.15
|
dnr after sadm
| 7
| 52
| 6.699219
| 150
| 20
| 38.09375
| 164
| 3.099609
| 0.5
| 3.299805
| 132
| 7.379883
| 273
| 70
| 4,352
| null | 1
|
<2 mo. follow-up
| 1
| 8
| 1
|
82.98999
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
$11-$25k
| 0
| 51,711
| 26,562
| 33,344.6562
| 22
|
white
| 18.796875
| 29
| 0.817993
| 0.704956
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 12
| 73
| 9.5
| 60
| 28
| 36.19531
| null | 3.899902
| 1
| 1.899902
| 139
| null | 113
| 32
| 4,750
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 220
| 1
|
72.77496
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
|
under $11k
| 0
| 28,137
| 14,024.8984
| 12,920.5469
| 16.5
|
black
| 16.398438
| 16
| 0.845947
| 0.746948
| 1
| 0
| 0
|
yes
| 0.85
| 0.75
|
no dnr
| 9
| 115
| 5.099609
| 60
| 20
| 36.59375
| null | null | 0.799927
| 0.799927
| 135
| null | 120
| 17
| 1,170
| 3
| 4
|
adl>=4 (>=5 if sur)
| 4
| 103
| 1
|
70.04498
|
female
| 0
| 18
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 9
|
under $11k
| 26
| 119,685
| 45,163.6875
| 47,995.375
| 32.333313
|
black
| 21.199219
| 34
| 0.758911
| 0.61792
| 1
| 1
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 18
| 112
| 14.398438
| 115
| 26
| 38
| 237.5
| null | null | 1.199951
| 148
| 7.349609
| 330
| 22
| 982
| null | 5
|
adl>=4 (>=5 if sur)
| 5
| 139
| 1
|
43.93198
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
under $11k
| 55
| 57,142
| 20,929.6562
| 21,162.0156
| 25
|
white
| 33.195313
| 39
| 0.488953
| 0.370972
| 2
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 9
| 118
| 15.199219
| 95
| 40
| 38.5
| 111.65625
| null | null | 2.899902
| 151
| 7.15918
| 161
| 16
| 8,115
| null | 1
|
no(M2 and SIP pres)
| 1
| 914
| 0
|
70.61694
|
female
| 0
| 22
|
Coma
|
Coma
| 2
| 14
|
$25-$50k
| 44
| 75,372
| 34,204.4375
| 71,189.4375
| 19
|
white
| 17.796875
| 19
| 0.606934
| 0.542969
| 1
| 0
| 0
|
no
| 0.15
| 0.1
|
dnr after sadm
| 2
| 60
| 9.5
| 115
| 9
| 38
| 380
| 2.799805
| 0.5
| 0.699951
| 139
| 7.419922
| 150
| 5
| 1,940
| null | 7
| null | 7
| 913
| 0
|
38.07797
|
female
| 0
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 16
|
$11-$25k
| 0
| 51,241
| 13,257.8125
| 8,457.69531
| 18
|
white
| 22.398438
| 28
| 0.660889
| 0.563965
| 4
| 0
| 0
|
metastatic
| 0.97
| 0.7
|
no dnr
| 4
| 67
| 9.398438
| 108
| 24
| 35.79688
| 410
| 2.199707
| 0.599976
| 1.399902
| 131
| 7.399414
| 104
| 37
| 2,850
| null | null | null | 2.429688
| 911
| 0
|
38.90997
|
female
| 0
| 5
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| 11
| null | 0
| 19,379
| 9,072.9062
| 10,849.0078
| 23
|
white
| 22.296875
| 22
| 0.860962
| 0.769897
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 5
| 72
| 6.5
| 75
| 24
| 37.59375
| null | null | 6.399414
| 0.299988
| 136
| null | 89
| 6
| 2,519
| null | 0
|
SIP>=30
| 0
| 232
| 1
|
27.29099
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 50,203
| 21,781.4844
| 21,434.4688
| 13
|
white
| 35.695313
| 51
| 0.764893
| 0.689941
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 11
| 107
| 16.796875
| 125
| 35
| 39.39844
| 96
| 3.599609
| 0.299988
| 2.399902
| 144
| 7.429688
| 128
| 28
| 1,741
| null | null | null | 3.161621
| 910
| 0
|
20.85399
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 15
|
>$50k
| 0
| 20,579
| 11,638.5703
| 8,873.57812
| 9.5
|
hispanic
| 27.398438
| 35
| 0.901978
| 0.835938
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 8
| 52
| 8.699219
| 125
| 16
| 36.09375
| null | null | 1
| 1.599854
| 137
| null | 92
| 30
| 2,825
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 909
| 0
|
55.767
|
male
| 0
| 10
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 30,453
| 12,746.4297
| 13,067.5625
| 18
|
white
| 37
| 45
| 0.201996
| 0.018997
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.5
|
no dnr
| 10
| 52
| 14.798828
| 112
| 32
| 39.69531
| null | 2
| 0.699951
| 1.199951
| 132
| null | 85
| 19
| 1,630
| null | null |
<2 mo. follow-up
| 3.716309
| 46
| 1
|
42.09399
|
female
| 0
| 12
|
Lung Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 43,422
| 21,040.4531
| 19,418.4688
| 7.5
|
black
| 12
| 12
| 0.830933
| 0.631958
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.6
|
no dnr
| 12
| 81
| 14
| 120
| 16
| 36.39844
| null | 4.199219
| 0.099991
| 1
| 139
| null | 97
| 7
| 2,220
| 2
| 3
| null | 3
| 219
| 1
|
78.81995
|
female
| 0
| 57
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null |
under $11k
| 26
| 436,904
| 161,974.25
| 329,348.75
| 30.75
|
white
| 30.398438
| 47
| 0.426941
| 0.306946
| 6
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 11
| 128
| 10.398438
| 120
| 12
| 37.59375
| 143.75
| 2.799805
| null | 2.699707
| 146
| 7.40918
| 62
| 58
| 4,600
| null | 6
| null | 6
| 437
| 1
|
65.74695
|
female
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 44
| 130,357
| 47,683.0625
| 58,079.3438
| 29.666656
|
white
| 34.09375
| 53
| 0.258972
| 0.153992
| 3
| 0
| 0
|
yes
| 0.8
| 0.3
|
no dnr
| 21
| 67
| 13.599609
| 55
| 8
| 38
| 105.09375
| null | 20.097656
| 1.299805
| 135
| 7.5
| null | null | 4,017
| null | null | null | 3.033691
| 186
| 1
|
50.01199
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 16
|
>$50k
| 0
| 9,518
| 4,221.1719
| 4,356.33984
| 10
|
black
| 20.699219
| 26
| 0.668945
| 0.368958
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.65
|
dnr after sadm
| 2
| 69
| 55
| 76
| 20
| 36.39844
| null | null | null | 0.699951
| 133
| null | null | 20
| 2,050
| 5
| null |
<2 mo. follow-up
| 3.854981
| 6
| 1
|
23.24699
|
male
| 1
| 23
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
>$50k
| 0
| 419,195
| 115,365.25
| 102,054.688
| 36.333313
|
white
| 44.09375
| 97
| 0.127991
| 0.057999
| 19
| 0
| 0
|
yes
| 0.2
| 0.1
|
no dnr
| 23
| 67
| 0.049995
| 145
| 42
| 38.39844
| 144.875
| null | 8.699219
| 1.699951
| 145
| 7.289062
| 598
| 69
| 3,920
| null | 0
|
<2 mo. follow-up
| 0
| 23
| 1
|
38.418
|
male
| 0
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 11
| null | 26
| 257,291
| null | null | 22.5
|
white
| 23.5
| 28
| 0.803955
| 0.738892
| 5
| 0
| 0
|
no
| null | null |
no dnr
| 34
| 65
| 12.599609
| 55
| 16
| 39
| 160
| null | null | 0.799927
| 133
| 7.459961
| 102
| 20
| 2,745
| null | null | null | 2.799805
| 905
| 0
|
91.25299
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
| null | 0
| 23,547
| 9,465.8984
| 10,411.125
| 21
|
white
| 29.898438
| 40
| 0.55188
| 0.35498
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 6
| 55
| 8.699219
| 50
| 16
| 36
| 236.71875
| null | null | 1.699951
| 125
| 7.139648
| 109
| 36
| 1,475
| 0
| 0
| null | 0
| 440
| 1
|
45.31097
|
male
| 0
| 11
|
Colon Cancer
|
Cancer
| 2
| 12
|
$11-$25k
| 0
| 32,838
| 14,494.5859
| 16,710.1719
| 14.5
|
white
| 14.898438
| 21
| 0.871948
| 0.712891
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 11
| 125
| 7.899414
| 74
| 22
| 38.5
| null | null | 2.399902
| 0.699951
| 140
| null | 111
| 10
| 1,800
| 0
| 1
| null | 1
| 93
| 1
|
49.16898
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 8
| 13
|
$25-$50k
| 0
| 59,761
| 18,474.4688
| 19,510.7656
| 24
|
white
| 32.695313
| 58
| 0.707886
| 0.618896
| 2
| 1
| 0
|
no
| null | null |
dnr after sadm
| 2
| 55
| 14.798828
| 115
| 20
| 36.29688
| 479.5625
| 3.099609
| null | 6.799805
| 130
| 7.349609
| null | 43
| 0
| 5
| 3
|
<2 mo. follow-up
| 3
| 15
| 1
|
27.058
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
under $11k
| 0
| 194,402
| 76,774.375
| 190,487.75
| 52
|
white
| 55.195313
| 111
| 0.274963
| 0.166992
| 1
| 0
| 0
|
no
| 0.25
| 0.25
|
dnr after sadm
| 10
| 38
| 5.799805
| 165
| 14
| 35.5
| 118.75
| 2.899902
| 4.699219
| 5.5
| 148
| 7.089844
| 9
| 28
| 206
| null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
65.99896
|
male
| 0
| 5
|
Colon Cancer
|
Cancer
| 1
| 18
|
$25-$50k
| 0
| 3,792
| 2,358.4785
| 2,450.26953
| 9
|
black
| 19.398438
| 17
| 0.779907
| 0.540894
| 1
| 0
| 0
|
metastatic
| 0.25
| 0.05
|
no dnr
| 5
| 77
| 6.299805
| 64
| 24
| 36.39844
| null | 3.799805
| 1.399902
| 1.299805
| 124
| null | 121
| 15
| 1,935
| 0
| null | null | 0.494751
| 62
| 1
|
70.03699
|
female
| 0
| 9
|
Lung Cancer
|
Cancer
| 2
| 14
|
under $11k
| 0
| 14,609
| 7,164.4805
| 6,895.14844
| 8.5
|
black
| 28.699219
| 26
| 0.392944
| 0.098999
| 1
| 1
| 0
|
metastatic
| 0.2
| 0
|
dnr after sadm
| 1
| 73
| 10.699219
| 136
| 32
| 39.09375
| null | null | null | 0.599976
| 126
| null | 162
| 8
| 2,200
| 3
| 5
|
<2 mo. follow-up
| 5
| 36
| 1
|
60.504
|
male
| 1
| 8
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 3
| 13
|
under $11k
| 0
| 49,985
| 25,018.3438
| 23,997.1562
| 36
|
white
| 33
| 60
| 0.50293
| 0.301941
| 1
| 0
| 0
|
no
| 0.3
| 0.15
|
dnr after sadm
| 8
| 62
| 15.199219
| 60
| 22
| 36.39844
| null | 2.399902
| 19.796875
| 3.399902
| 145
| null | 188
| 131
| 700
| null | null |
<2 mo. follow-up
| 3.048828
| 8
| 1
|
29.53299
|
male
| 0
| 28
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 17
|
under $11k
| 0
| 102,427
| 46,724
| 48,618.5625
| 17.5
|
black
| 21.597656
| 12
| 0.767944
| 0.69397
| 2
| 0
| 0
|
yes
| 0.9
| 0.6
|
no dnr
| 28
| 81
| 5.599609
| 125
| 22
| 36.79688
| null | null | null | 1.299805
| 138
| null | null | 12
| 3,000
| 0
| null | null | 0.494751
| 102
| 1
|
53.07599
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 16
|
>$50k
| 0
| 29,187
| 13,135.7578
| 14,763.3984
| 17
|
hispanic
| 22.398438
| 21
| 0.797974
| 0.674927
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 7
| 55
| 8.699219
| 100
| 18
| 36
| null | null | 1.5
| 0.799927
| 135
| null | 86
| 10
| 2,080
| 1
| 4
|
adl>=4 (>=5 if sur)
| 4
| 892
| 0
|
67.784
|
female
| 1
| 51
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
| null | 41
| 411,846
| 147,752.125
| 165,394.125
| 38.25
|
white
| 17.398438
| 32
| 0.741943
| 0.660889
| 6
| 0
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 49
| 65
| 17.199219
| 65
| 8
| 37.69531
| 351
| 2.699707
| 3.099609
| 1.099854
| 139
| 7.55957
| 94
| 9
| 1,625
| null | 2
|
<2 mo. follow-up
| 2
| 51
| 1
|
53.26199
|
female
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
>$50k
| 0
| 203,408
| 78,476.3125
| 208,533.75
| 62
|
white
| 42.195313
| 86
| 0.473999
| 0.355957
| 1
| 0
| 0
|
no
| 0.3
| 0.3
|
dnr after sadm
| 7
| 72
| 5.299805
| 125
| 12
| 35.39844
| 85
| 2.899902
| 12.099609
| 1.599854
| 143
| 7.419922
| 332
| 66
| 140
| null | 5
|
<2 mo. follow-up
| 5
| 8
| 1
|
59.17599
|
female
| 1
| 5
|
Coma
|
Coma
| 0
| 15
|
$25-$50k
| 100
| 31,803
| 13,809.9688
| 15,185.8594
| 32
|
white
| 20.796875
| 55
| 0.355957
| 0.282959
| 1
| 0
| 0
|
no
| 0.1
| 0.1
|
dnr after sadm
| 3
| 141
| 1.299805
| 125
| 32
| 38.59375
| 207.5
| 2.099609
| 0.599976
| 0.699951
| 137
| 7.519531
| 207
| 27
| 1,448
| null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
47.21997
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 14
|
under $11k
| 0
| 14,827
| 8,235.9219
| 6,062.54688
| 7.5
|
white
| 15.699219
| 23
| 0.931885
| 0.883911
| 1
| 1
| 0
|
no
| 0.85
| 0.8
|
no dnr
| 7
| 75
| 5.899414
| 75
| 32
| 37.5
| null | null | null | 1.5
| 138
| null | 102
| 19
| 2,100
| 4
| 3
|
adl>=4 (>=5 if sur)
| 3
| 426
| 1
|
54.021
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 6,533
| 3,276.0098
| 3,331.62891
| 14
|
white
| 15.599609
| 24
| 0.758911
| 0.504883
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.5
|
no dnr
| 4
| 65
| 3.899902
| 56
| 12
| 38
| null | null | 0.299988
| 0.899902
| 140
| null | null | 13
| 1,225
| null | null | null | 2.495606
| 116
| 1
|
81.25397
|
female
| 0
| 12
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 15,945
| 8,343.2969
| 9,195.6875
| 4
|
white
| 15
| 8
| 0.709961
| 0.428955
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.05
|
dnr after sadm
| 1
| 81
| null | 76
| 28
| 36.59375
| null | null | null | null | 140
| null | null | null | 2,800
| 3
| 4
|
adl>=4 (>=5 if sur)
| 4
| 62
| 1
|
91.43896
|
female
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 61
| 68,103
| 31,396.25
| 32,957.5
| 25.666656
|
white
| 16.5
| 46
| 0.626953
| 0.522949
| 1
| 0
| 0
|
no
| 0.4
| 0.1
|
dnr after sadm
| 7
| 75
| 9.5
| 75
| 37
| 36.5
| 562.75
| 2.099609
| 0.5
| 1.099854
| 134
| 7.599609
| 202
| 24
| 670
| null | 6
|
adl>=4 (>=5 if sur)
| 6
| 883
| 0
|
65.31696
|
male
| 0
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 16
|
>$50k
| 37
| 80,470
| 10,313.6797
| 12,423.3125
| 33
|
white
| 26.699219
| 64
| 0.582886
| 0.472961
| 4
| 1
| 0
|
no
| 0.5
| 0.25
|
no dnr
| 3
| 65
| 12
| 65
| 22
| 37.59375
| 134.53125
| 2.299805
| null | 9.398438
| 132
| 7.389648
| 322
| 103
| 0
| null | 2
| null | 2
| 312
| 1
|
48.94998
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 12,684
| 6,731.8086
| 6,553.53906
| 17
|
hispanic
| 19.398438
| 7
| 0.905884
| 0.840942
| 1
| 0
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 5
| 107
| 6.899414
| 105
| 22
| 36
| null | null | null | 0.799927
| 136
| null | 105
| 12
| 2,470
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 881
| 0
|
54.853
|
male
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 26
| 272,366
| 77,111.5625
| 117,935.188
| 37.25
|
white
| 27.398438
| 46
| 0.639893
| 0.537964
| 10
| 0
| 0
|
no
| null | null |
no dnr
| 37
| 72
| 8.5
| 125
| 26
| 39.39844
| 174
| null | 3
| 1.699951
| 142
| 7.489258
| 122
| 32
| 3,411
| null | null | null | 3.483887
| 174
| 1
|
75.16797
|
female
| 0
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 14
|
$25-$50k
| 0
| 31,213
| 14,603.8047
| 16,043.125
| 18
|
asian
| 27.898438
| 30
| 0.513916
| 0.396973
| 1
| 1
| 0
|
metastatic
| 0.15
| 0.1
|
dnr after sadm
| 2
| 109
| 14.199219
| 125
| 14
| 36.29688
| 357.125
| null | null | 1.099854
| 125
| 7.479492
| 342
| 15
| 1,656
| null | 4
|
<2 mo. follow-up
| 4
| 26
| 1
|
70.16296
|
male
| 0
| 27
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$25-$50k
| 0
| 159,568
| 92,464.625
| 77,863.1875
| 19.25
|
white
| 26.5
| 34
| 0.75293
| 0.609985
| 1
| 0
| 0
|
no
| 0.7
| 0.5
|
no dnr
| 27
| 53
| 5.5
| 105
| 18
| 36.5
| null | null | null | 2.099609
| 134
| null | 107
| 29
| 3,490
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 879
| 0
|
91.08795
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 20
|
>$50k
| 9
| 34,662
| 18,039.8906
| 18,089.8281
| 13
|
white
| 19.796875
| 27
| 0.751953
| 0.672974
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 1
| 110
| 11.798828
| 105
| 33
| 38
| 330
| null | null | 0.899902
| 145
| 7.589844
| 220
| 11
| 650
| null | 0
| null | 0
| 387
| 1
|
50.76797
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 19
|
>$50k
| 0
| 312,860
| 36,578.3438
| 35,032.4375
| 39
|
white
| 42.695313
| 97
| 0.333984
| 0.218994
| 47
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 2
| 58
| 11.398438
| 70
| 35
| 36.79688
| 109.07812
| 2.199707
| 19.796875
| 3.699707
| 148
| 7.609375
| 206
| 50
| 0
| null | 0
|
<2 mo. follow-up
| 0
| 8
| 1
|
29.77399
|
male
| 0
| 36
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$25-$50k
| 44
| 333,521
| 151,389.25
| 165,328.875
| 33
|
white
| 37.796875
| 77
| 0.449951
| 0.329956
| 7
| 0
| 0
|
no
| 0.35
| 0.35
|
no dnr
| 36
| 65
| 25.296875
| 120
| 45
| 36.89844
| 168
| 2.199707
| 7.099609
| 1.799805
| 155
| 7.479492
| 184
| 53
| 1,665
| null | 0
|
no(M2 and SIP pres)
| 0
| 878
| 0
|
63.37
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 11
| null | 94
| 65,661
| 26,997.4688
| 29,392.3125
| 66
|
hispanic
| 51.898438
| 88
| 0
| 0
| 2
| 1
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 5
| 55
| 6.199219
| 55
| 24
| 36
| 80
| 3.299805
| 42
| 4.599609
| 145
| 7.199219
| 347
| 56
| 105
| null | 7
|
<2 mo. follow-up
| 7
| 6
| 1
|
38.80399
|
female
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 44
| 407,955
| 125,929.75
| 132,617.125
| 47
|
hispanic
| 34.296875
| 57
| 0.474976
| 0.356995
| 10
| 0
| 0
|
no
| 0.4
| 0.4
|
dnr after sadm
| 15
| 70
| 1.399902
| 65
| 30
| 36.39844
| 287.5
| 2.399902
| 24.296875
| 1.299805
| 141
| 7.40918
| 167
| 51
| 1,713
| null | 5
|
<2 mo. follow-up
| 5
| 16
| 1
|
77.50598
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 32,303
| 13,342.4531
| 13,298.7656
| 10
|
white
| 16.699219
| 26
| 0.841919
| 0.740967
| 1
| 0
| 0
|
no
| 0.5
| 0.2
|
dnr before sadm
| -1
| 70
| 11.298828
| 68
| 22
| 37.5
| 250
| null | 1.299805
| 0.699951
| 145
| 7.429688
| null | 23
| 810
| null | null |
<2 mo. follow-up
| 4.378906
| 13
| 1
|
65.90796
|
female
| 0
| 6
|
Colon Cancer
|
Cancer
| 1
| 17
|
>$50k
| 0
| 9,327
| 5,024.7109
| 5,283.13672
| 13
|
white
| 17.5
| 5
| 0.80896
| 0.591919
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.6
|
no dnr
| 6
| 85
| 9.199219
| 82
| 20
| 36.59375
| null | 3.199707
| 0.599976
| 0.799927
| 139
| null | null | 9
| null | null | null |
no(M2 and SIP pres)
| 1.984375
| 115
| 1
|
23.84399
|
female
| 0
| 29
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 15
|
$11-$25k
| 0
| 215,913
| 73,125.5
| 81,951.375
| 25
|
hispanic
| 28.199219
| 37
| 0.601929
| 0.494995
| 6
| 0
| 0
|
yes
| 0.8
| 0.7
|
no dnr
| 29
| 82
| 0.049995
| 150
| 24
| 38.39844
| null | null | null | 0.799927
| 137
| null | null | 6
| 2,250
| null | 0
|
no(M2 and SIP pres)
| 0
| 105
| 1
|
58.724
|
male
| 1
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 20
|
>$50k
| 41
| 461,154
| 180,363.75
| 168,425.75
| 51.666657
|
white
| 37.898438
| 104
| 0.27594
| 0.167999
| 5
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 19
| 58
| 9.898438
| 115
| 26
| 39
| 116
| 2.799805
| 8.5
| 2.099609
| 139
| 7.149414
| 71
| 55
| 160
| null | 0
|
<2 mo. follow-up
| 0
| 19
| 1
|
79.71497
|
female
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
>$50k
| 26
| 241,269
| 55,635.25
| 56,483.1562
| 35
|
white
| 21.898438
| 42
| 0.541992
| 0.426941
| 16
| 0
| 0
|
yes
| 0.75
| 0.7
|
no dnr
| 24
| 58
| 12.699219
| 75
| 30
| 36.39844
| 268
| 2.699707
| 0.299988
| 1.599854
| 132
| 7.419922
| 164
| 30
| 3,510
| null | 0
|
no(M2 and SIP pres)
| 0
| 870
| 0
|
48.81897
|
male
| 1
| 5
|
Lung Cancer
|
Cancer
| 1
| 16
| null | 26
| 14,258
| 7,296.1016
| 8,209.88281
| 20
|
black
| 27.097656
| 27
| 0.377991
| 0.089996
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 3
| 101
| 6.599609
| 146
| 22
| 38.39844
| 120.40625
| 3.199707
| 0.199982
| 0.899902
| 141
| 7.429688
| 144
| 19
| 2,600
| null | 4
|
<2 mo. follow-up
| 4
| 5
| 1
|
41.98798
|
male
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 37
| 501,348
| 63,796.875
| 59,837.3125
| 39
|
white
| 27.898438
| 66
| 0.632935
| 0.529907
| 27
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 16
| 58
| 11.898438
| 135
| 10
| 38.69531
| 252.5
| 4.699219
| 1.099854
| 6.099609
| 139
| 7.40918
| 247
| 90
| 0
| null | 0
|
SIP>=30
| 0
| 866
| 0
|
79.04199
|
male
| 1
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 14
| null | 44
| 274,616
| 73,806.375
| 74,751.75
| 44
|
white
| 33.296875
| 54
| 0.225983
| 0.126984
| 10
| 0
| 0
|
no
| 0.1
| 0.1
|
dnr after sadm
| 9
| 62
| 12.199219
| 115
| 14
| 38.39844
| 105
| null | 11.298828
| 1.199951
| 138
| 7.449219
| 201
| 32
| 1,925
| null | 0
|
<2 mo. follow-up
| 0
| 17
| 1
|
44.616
|
male
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
under $11k
| 0
| 71,501
| 34,153.9062
| 38,849.9375
| 25
|
white
| 42.09375
| 28
| 0.565918
| 0.370972
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 16
| 42
| 7.5
| 105
| 14
| 36
| null | 3
| 3.199707
| 1.099854
| 126
| null | 106
| 19
| 2,625
| 4
| 5
| null | 5
| 866
| 0
|
24.21899
|
male
| 1
| 3
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 13
| null | 55
| 106,744
| 14,836.7031
| 16,656.7656
| 31
|
black
| 72.1875
| 91
| 0
| 0
| 22
| 0
| 0
|
yes
| 0.02
| 0
|
dnr after sadm
| 2
| 5
| 5.099609
| 0
| 35
| 36.09375
| 420
| null | null | 4.899414
| 138
| 7.069336
| null | 47
| 88
| null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
66.146
|
male
| 1
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 17
|
$25-$50k
| 0
| 44,384
| 19,614.8125
| 22,711.1094
| 40
|
white
| 31.699219
| 47
| 0.67395
| 0.50293
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 7
| 52
| 9.898438
| 65
| 16
| 36
| null | 3.399902
| 1.799805
| 1.899902
| 126
| null | 204
| 51
| 650
| 0
| 0
|
<2 mo. follow-up
| 0
| 7
| 1
|
58.53
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 8,325
| 4,990.1484
| 4,167.06641
| 18
|
asian
| 25.898438
| 46
| 0.810913
| 0.694946
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 5
| 53
| 6.799805
| 115
| 20
| 36.39844
| null | 3.899902
| 2.199707
| 2
| 136
| null | 171
| 49
| 4,050
| null | 1
| null | 1
| 864
| 0
|
41.54999
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 21
|
under $11k
| 0
| 31,741
| 15,434.2344
| 16,267.9141
| 14
|
white
| 21.597656
| 24
| 0.903931
| 0.838989
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 8
| 55
| 6.899414
| 115
| 16
| 36
| null | 3.599609
| 1.299805
| 1.199951
| 132
| null | 88
| 13
| 3,300
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 864
| 0
|
75.146
|
female
| 0
| 8
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 22,930
| 10,770.4922
| 11,152.2422
| 10
|
white
| 11.199219
| 16
| 0.868896
| 0.704956
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 8
| 72
| 10.398438
| 84
| 20
| 37.79688
| null | 3.799805
| 0.399963
| 0.699951
| 136
| null | 147
| 7
| 1,025
| null | null | null | 2.500488
| 746
| 1
|
21.922
|
male
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 407,547
| 133,430.75
| 129,080.562
| 44
|
hispanic
| 24.597656
| 45
| 0.882935
| 0.840942
| 7
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 37
| 67
| 15.398438
| 140
| 16
| 38
| 162.5
| null | 0.299988
| 0.799927
| 135
| 7.5
| 194
| 39
| 4,920
| null | null |
no(M2 and SIP pres)
| 2.060547
| 864
| 0
|
58.09998
|
female
| 1
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 2
| null | null | 55
| 197,978
| 16,211.4844
| 17,017.625
| 33
|
white
| 53.695313
| 116
| 0
| 0
| 35
| 1
| 0
|
yes
| 0.1
| 0.05
|
dnr after sadm
| 2
| 37
| 0.199982
| 115
| 4
| 36.79688
| 310
| null | 5.599609
| 1.899902
| 139
| 7.219727
| 211
| 74
| 114
| null | null |
<2 mo. follow-up
| 2.914551
| 4
| 1
|
89.77997
|
male
| 1
| 3
|
Coma
|
Coma
| 2
| null | null | 100
| 19,078
| 8,106.625
| 10,791.7031
| 28
|
white
| 15.5
| 31
| 0.201996
| 0.140991
| 1
| 0
| 1
|
no
| null | null |
dnr after sadm
| 1
| 78
| 17.296875
| 80
| 9
| 38.5
| 237.5
| null | null | 1.199951
| 149
| 7.449219
| 107
| 39
| 350
| null | null |
<2 mo. follow-up
| 5.645508
| 3
| 1
|
60.61298
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 42,604
| 23,808.5781
| 25,027.375
| 16.5
|
hispanic
| 18.597656
| 38
| 0.886963
| 0.810913
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 12
| 55
| 5.799805
| 45
| 16
| 36.19531
| null | 4.199219
| 0.5
| 1.599854
| 133
| null | 119
| 25
| 2,770
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 754
| 1
|
52.87097
|
male
| 0
| 54
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 11
|
$25-$50k
| 26
| 509,887
| 150,755.75
| 138,829.5
| 42.75
|
white
| 25
| 57
| 0.700928
| 0.611938
| 10
| 0
| 0
|
no
| 0.6
| 0.6
|
no dnr
| 54
| 125
| 7.899414
| 105
| 42
| 38
| null | 2.399902
| 9
| 0.699951
| 135
| null | 184
| 45
| 2,080
| null | 2
|
adl>=4 (>=5 if sur)
| 2
| 861
| 0
|
94.55194
|
male
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$11-$25k
| 0
| 40,533
| 16,502.4688
| 18,087.75
| 43
|
white
| 61.296875
| 83
| 0
| 0
| 1
| 0
| 0
|
no
| 0
| 0
|
dnr after sadm
| 3
| 13
| 11.099609
| 45
| 8
| 35.59375
| 202.5
| 3.299805
| 3.199707
| 2
| 147
| 7.329102
| 205
| 49
| 360
| null | 0
|
<2 mo. follow-up
| 0
| 4
| 1
|
29.53
|
female
| 0
| 32
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 15
|
$11-$25k
| 0
| 89,501
| 37,115
| 33,926.4375
| 8.75
|
asian
| 21.296875
| 42
| 0.916992
| 0.886963
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 32
| 65
| 28.199219
| 74
| 22
| 36.59375
| 612
| 1.099854
| null | 1.399902
| 127
| 7.399414
| 158
| 38
| 600
| 0
| 0
|
SIP>=30
| 0
| 852
| 0
|
75.10999
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| 14
|
$25-$50k
| 0
| 8,323
| 4,449.6875
| 4,317.80859
| 15
|
asian
| 27.597656
| 42
| 0.407959
| 0.108994
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.15
|
dnr before sadm
| -1
| 73
| 8.298828
| 128
| 30
| 35.59375
| null | null | null | 2.099609
| 135
| null | 152
| 31
| 1,475
| 2
| null |
<2 mo. follow-up
| 1.838867
| 49
| 1
|
83.13495
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 47,079
| 21,050.375
| 20,225.4844
| 14.666664
|
hispanic
| 31.597656
| 48
| 0.461975
| 0.34198
| 2
| 0
| 0
|
yes
| 0.2
| 0.05
|
dnr after sadm
| 2
| 103
| 25.898438
| 130
| 20
| 39.5
| 372
| 2.399902
| 21.796875
| 1.399902
| 140
| 7.419922
| null | 27
| 2,900
| null | null | null | 3.766113
| 95
| 1
|
38.93799
|
male
| 1
| 53
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 26
| 1,045,982
| 211,981.5
| 213,677.5
| 47.25
|
hispanic
| 26.597656
| 51
| 0.706909
| 0.61792
| 115
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 51
| 78
| 3.299805
| 140
| 48
| 38.79688
| 212.5
| 1.799805
| 0.399963
| 1.099854
| 146
| 7.369141
| 150
| 24
| 3,970
| null | 6
|
<2 mo. follow-up
| 6
| 53
| 1
|
61.70599
|
female
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 10
|
under $11k
| 26
| 60,681
| 23,473.4219
| 29,124.5156
| 32
|
white
| 42.796875
| 102
| 0.261963
| 0.155975
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 6
| 58
| 15.5
| 165
| 38
| 38.59375
| 162.5
| null | 13.099609
| 4.699219
| 149
| 7.619141
| 94
| 86
| 70
| null | 5
|
<2 mo. follow-up
| 5
| 6
| 1
|
49.32199
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
>$50k
| 0
| 193,938
| 33,939.4688
| 32,411.4844
| 24.333328
|
white
| 30.199219
| 48
| 0.701904
| 0.611938
| 12
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 15
| 56
| 5.199219
| 130
| 32
| 36.39844
| null | null | null | 1.899902
| 135
| null | null | 58
| 3,210
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 130
| 1
|
72.26794
|
male
| 0
| 19
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
$25-$50k
| 0
| 77,088
| 32,681.6719
| 33,255.2188
| 27
|
white
| 24.199219
| 35
| 0.726929
| 0.642944
| 1
| 0
| 0
|
yes
| 0.9
| 0.9
|
no dnr
| 19
| 68
| 7.699219
| 55
| 24
| 36.59375
| 202.84375
| 3.199707
| 0.299988
| 2.599609
| 130
| 7.509766
| null | 55
| 2,608
| null | 1
|
no(M2 and SIP pres)
| 1
| 848
| 0
|
59.81897
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 0
| 11
|
$25-$50k
| 0
| 12,972
| 5,645.2266
| 5,480.20703
| 18
|
black
| 18
| 22
| 0.893921
| 0.821899
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 4
| 84
| 16.796875
| 66
| 26
| 36.79688
| 323.75
| null | null | 1.299805
| 139
| 7.389648
| 107
| 26
| 4,000
| null | 0
| null | 0
| 846
| 0
|
79.98895
|
male
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 13
|
$25-$50k
| 0
| 17,986
| 7,659.9102
| 6,822.23828
| 20
|
black
| 25.199219
| 41
| 0.688965
| 0.522949
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 6
| 74
| 3.799805
| 102
| 20
| 37.59375
| 195.21875
| 2.899902
| 0.399963
| 2.399902
| 141
| 7.30957
| 86
| 30
| 4,820
| 0
| null |
SIP>=30
| 0.494751
| 846
| 0
|
67.35699
|
male
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 20
|
>$50k
| 0
| 36,549
| 17,240.5625
| 17,851.75
| 25.5
|
white
| 24.796875
| 33
| 0.792969
| 0.666992
| 1
| 0
| 0
|
no
| 0.55
| 0.4
|
no dnr
| 8
| 58
| 9.699219
| 95
| 14
| 36.09375
| null | 3.099609
| 0.799927
| 1.5
| 130
| null | 108
| 24
| 3,100
| 4
| null |
no(M2 and SIP pres)
| 3.183106
| 627
| 1
|
70.29199
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 13
|
under $11k
| 0
| 22,123
| 13,162.875
| 11,510.5469
| 8
|
black
| 19.097656
| 18
| 0.855957
| 0.761963
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 9
| 103
| 7.299805
| 115
| 24
| 37
| null | 3.299805
| 1.099854
| 1.099854
| 140
| null | 135
| 15
| 1,970
| 2
| 0
|
SIP>=30
| 0
| 844
| 0
|
77.42096
|
female
| 1
| 3
|
Coma
|
Coma
| 0
| null | null | 100
| 93,782
| 9,460.7344
| 9,443.10938
| 30
|
white
| 38.695313
| 55
| 0
| 0
| 18
| 0
| 0
|
no
| 0
| 0
|
dnr before sadm
| 0
| 72
| 41.5
| 80
| 14
| 35.5
| 122.5
| null | 0.099991
| 0.399963
| 119
| 7.599609
| 127
| 27
| 84
| null | null |
<2 mo. follow-up
| 3.126953
| 3
| 1
|
82.29395
|
male
| 0
| 6
|
Coma
|
Coma
| 2
| null | null | 44
| 39,770
| 16,190.4453
| 19,527.0469
| 26
|
white
| 20
| 51
| 0.406982
| 0.332947
| 2
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 6
| 62
| 21.5
| 65
| 50
| 38.29688
| 271.375
| 2.199707
| null | 1.199951
| 147
| 7.429688
| 215
| 30
| 1,590
| null | null | null | 2.861816
| 529
| 1
|
56.02698
|
male
| 0
| 18
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 14
|
$11-$25k
| 0
| 32,470
| 20,180.0156
| 14,304.4688
| 13
|
white
| 24
| 24
| 0.844971
| 0.744995
| 1
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 18
| 90
| 10.099609
| 120
| 20
| 36.79688
| null | 3.799805
| null | 3.299805
| 141
| null | 105
| 37
| 4,130
| 1
| null |
SIP>=30
| 1.166748
| 295
| 1
|
64.88397
|
male
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 14
|
$25-$50k
| 0
| 221,993
| 45,616.8125
| 47,116.8125
| 30.5
|
white
| 35.898438
| 55
| 0.467957
| 0.348999
| 12
| 1
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 13
| 48
| 15.699219
| 95
| 22
| 36.79688
| null | null | null | 3.099609
| 127
| null | null | 60
| 100
| null | 5
|
<2 mo. follow-up
| 5
| 13
| 1
|
33.60699
|
male
| 0
| 18
|
Coma
|
Coma
| 0
| 16
|
>$50k
| 100
| 53,325
| 25,504.8125
| 43,346.9375
| 16
|
asian
| 23.296875
| 37
| 0.541992
| 0.472961
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 18
| 135
| 18.097656
| 150
| 9
| 38.59375
| 427.5
| 4.099609
| 0.699951
| 0.899902
| 133
| 7.429688
| 144
| 15
| 1,305
| null | 0
|
no(M2 and SIP pres)
| 0
| 842
| 0
|
88.91199
|
female
| 0
| 11
|
Coma
|
Coma
| 2
| 17
|
$25-$50k
| 41
| 43,891
| 17,630.4688
| 18,825.7969
| 17
|
black
| 22.699219
| 39
| 0.240997
| 0.175995
| 4
| 0
| 1
|
no
| 0.5
| 0.25
|
no dnr
| 11
| 131
| 15.099609
| 150
| 8
| 38
| 371.375
| null | null | 0.899902
| 134
| 7.399414
| null | 12
| 1,830
| null | 5
|
adl>=4 (>=5 if sur)
| 5
| 841
| 0
|
54.81198
|
male
| 0
| 54
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 653,743
| 92,126.8125
| 73,470.125
| 21.5
|
black
| 20.296875
| 37
| 0.823975
| 0.763916
| 80
| 1
| 0
|
no
| 0.95
| 0.95
|
no dnr
| 54
| 111
| 24.5
| 60
| 10
| 36.69531
| 520
| 2.099609
| 0.199982
| 0.799927
| 133
| 7.299805
| 194
| 34
| 3,080
| null | 0
|
no(M2 and SIP pres)
| 0
| 840
| 0
|
66.49396
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 28,819
| 12,945.9062
| 15,484.7188
| 11.5
|
white
| 23.597656
| 13
| 0.703979
| 0.417969
| 1
| 0
| 0
|
metastatic
| 1
| 0.9
|
no dnr
| 7
| 99
| null | 100
| 22
| 38
| 136.71875
| null | null | 1.099854
| 129
| 7.459961
| null | 11
| 2,640
| null | null | null | 2.890625
| 839
| 0
|
52.22198
|
male
| 0
| 16
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 14
|
under $11k
| 0
| 73,669
| 32,506.2969
| 32,569.6719
| 19
|
asian
| 24.5
| 29
| 0.704956
| 0.615967
| 1
| 0
| 0
|
yes
| 0.8
| 0.5
|
no dnr
| 16
| 78
| 5.599609
| 115
| 30
| 38.29688
| 614.25
| null | 1.299805
| 1.099854
| 128
| 7.479492
| 145
| 24
| 2,260
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 84
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.